Page last updated: 2024-08-23

lonidamine and Kidney Neoplasms

lonidamine has been researched along with Kidney Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Cao, W; Chen, J; Gao, S; Gao, Y; Ju, G; Ren, F; Wu, W; Wu, Z; Xiao, C; Xu, C1
Becker, H; Hoffmann, L; Köllermann, M; Müller, W; Possinger, K; Schlichter, A; Schmoll, E; Stahl, M; Wagner, H; Weidenhammer, W1
Band, PR; Besner, JG; Coppin, CM; Eisenhauer, EA; Stewart, D; Weinerman, BH1

Trials

2 trial(s) available for lonidamine and Kidney Neoplasms

ArticleYear
Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II study.
    Seminars in oncology, 1991, Volume: 18, Issue:2 Suppl 4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Evaluation; Female; Humans; Indazoles; Kidney Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate; Tamoxifen; Time Factors

1991
Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.
    Cancer treatment reports, 1986, Volume: 70, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Indazoles; Kidney Neoplasms; Male; Middle Aged; Nausea; Pain; Pyrazoles; Testis; Testosterone

1986

Other Studies

1 other study(ies) available for lonidamine and Kidney Neoplasms

ArticleYear
Photothermal therapy enhance the anti-mitochondrial metabolism effect of lonidamine to renal cell carcinoma in homologous-targeted nanosystem.
    Nanomedicine : nanotechnology, biology, and medicine, 2021, Volume: 34

    Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Delivery Systems; Humans; Indazoles; Indoles; Kidney Neoplasms; Mice; Mitochondria; Nanoparticles; Photothermal Therapy; Polymers; Silicon Dioxide; Xenograft Model Antitumor Assays

2021